Concepedia

Martin Erlanson

ME

44

Publications

3K

Citations

28

H-Index

1991

Active since

Affiliations

Umeå University(Current)

Lund University

Uppsala University Hospital

Karolinska University Hospital

Uppsala University

Martin Erlanson is an author at Umeå University specializing in medicine, oncology, and pathology.

Top concepts

Publications per year

1991–2020

44

Publications

44

Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01

Francesco d’Amore, Thomas Relander, Grete F. Lauritzsen et al. · Journal of Clinical Oncology · 2012 · 584 citations

A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas

Gunilla Enblad, Hans Hagberg, Martin Erlanson et al. · Blood · 2004 · 302 citations · Full text

Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis

Mattias Berglund, Ulf Thunberg, Rose‐Marie Amini et al. · Modern Pathology · 2005 · 202 citations · Full text

, , +10

Expression of Cyclin E and the Cyclin-Dependent Kinase Inhibitor p27 in Malignant Lymphomas—Prognostic Implications

Martin Erlanson, Cajsa Portin, Barbro Linderholm et al. · Blood · 1998 · 139 citations

Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women: a Swedish Lymphoma Registry Study

Henna Riikka Junlén, Stefan Peterson, Eva Kimby et al. · Leukemia · 2014 · 130 citations

, , +2

Rows per page

1–5 of 44